✦ LIBER ✦

PGS5 ECONOMIC BURDEN OF IRRITABLE BOWEL SYNDROME (IBS): ONE YEAR RESULTS. RITMO STUDY

✍ Scribed by X Badia; F Mearín; A Caballero; J Benavent; M Díaz-Rubio; E Domínguez; V Garrigues; J Vázquez; J Piqué; M Figueres; M Cucala; M Balañá; M Roset

Book ID: 119592671
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 87 KB
Volume: 6
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)61750-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Change over time of bowel habit in irrit

Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study)

✍ V. GARRIGUES; F. MEARIN; X. BADÍA; A. BALBOA; J. BENAVENT; A. CABALLERO; E. DOMÍ 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 536 KB

PGI11 THE ECONOMIC AND QUALITY OF LIFE B

PGI11 THE ECONOMIC AND QUALITY OF LIFE BURDEN OF ILLNESS IN CHRONIC CONSTIPATION (CC) AND IRRITABLE BOWEL SYNDROME (IBS): A SYSTEMATIC REVIEW

✍ K. Yee; D. Nellesen; A. Chawla; R. Carson; B. Lewis 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Economic and Quality-Of-Life Burden of M

Economic and Quality-Of-Life Burden of Moderate to Severe Irritable Bowel Syndrome with Constipation (IBS-C) in Spain: Interim Analysis of the IBIS-C Study

✍ Mearin, F.; Fortea, J.; Valveny, N.; Cortes, X.; Lindner, L.; Prior, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

M1254 Effectiveness of a Group Hypnother

M1254 Effectiveness of a Group Hypnotherapy Program for Irritable Bowel Syndrome, A One Year Follow-Up Study

✍ Gerson, Mary-Joan; Gerson, Mary-Joan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

377 A Randomized, Double-Blind, Placebo-

377 A Randomized, Double-Blind, Placebo-Controlled Trial with a Novel Dual Noradrenergic Reuptake Inhibitor (NARI) and 5-HT3 Antagonist: Results of a Phase II 8-Week Study in Female Patients with Diarrhea Predominant Irritable Bowel Syndrome (D-IBS)

✍ William G. Paterson; Jonathon Springer; Michael O'Mahony; Richard P. Reynolds; S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 95 KB

520 Efficacy of Ibodutant, a Selective A

520 Efficacy of Ibodutant, a Selective Antagonist of Neurokinin 2 Receptors, in Irritable Bowel Syndrome With Diarrhoea (IBS-D): The Results of a Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Phase II Study (the IRIS-2)

✍ Tack, Jan F.; Dochev, Yavor S.; Bochenek, Anna; Atanasov, Ivan; Horynski, Marek; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 639 KB